The neurobiology of depression: Perspectives from animal and human sleep studies

Neuroscientist

Volumn 9, Issue 1, 2003, Pages 82-98

  Shaffery, James ^b   Hoffmann, Robert ^b   Armitage, Roseanne ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Depression; Neurobiology; Sex differences; Sleep

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN MONOAMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLOMIPRAMINE; DESIPRAMINE; ESTROGEN; IPRINDOLE; NEUROTRANSMITTER; OXOTREMORINE; PROGESTERONE; SEROTONIN; SEX HORMONE; STEROID; TRIMIPRAMINE;

ADAPTATION; ANIMAL MODEL; CHOLINERGIC TRANSMISSION; COMORBIDITY; DEPRESSION; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; GONADECTOMY; HOMEOSTASIS; HORMONAL REGULATION; LEARNED HELPLESSNESS; LEARNING; LIFE EVENT; MATERNAL DEPRIVATION; MENTAL STRESS; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROTRANSMISSION; NONREM SLEEP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REM SLEEP; REVIEW; RISK FACTOR; SEROTONIN METABOLISM; SEX DIFFERENCE; SLEEP; SLEEP DEPRIVATION; SOCIAL ADAPTATION; SOCIAL SUPPORT; STRESS; SUBSTANCE ABUSE; SUICIDE ATTEMPT;

ACETYLCHOLINE; ANIMALS; BIOGENIC MONOAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; GONADAL STEROID HORMONES; HUMANS; SEX FACTORS; SLEEP DISORDERS; SLEEP STAGES; SLEEP, REM; STRESS;

EID: 0037309341     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858402239594     Document Type: Review

References (185)

1. Allen LS, Richey MF, Chai YM, Gorski RA. 1991. Sex differences in the corpus callosum of the living human being. J Neurosci 11:933-42.
2. American Psychiatric Association. 1994. Diagnotic and statistical manual of mental disorders: DSM-IV, 4th edition. Washington (DC): American Psychiatric Association.
3. Anisman H, Zacharko R. 1982. Depression: the predisposing influence of stress. Behav Brain Sci 5:89-137.
4. Armitage R. 1995. Microarchitectural findings in sleep EEG in depression: diagnostic implications. Biol Psychiatry 37:72-84.
5. Armitage R. 2000. The effects of antidepressants on sleep in patients with depression. Can J Psychiatry 45:803-9.
6. Armitage R, Hoffmann R. 1997. Sleep electrophysiology of major depressive disorders. Curr Rev Mood Anx Disord 1:139-51.
7. Armitage R, Hoffmann R, Fitch T, Trivedi M, Rush AJ. 2000. Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep 23:607-17.
8. Armitage R, Hoffmann R, Trivedi M, Rush AJ. 2000. Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 95:201-13.
9. Armitage R, Hoffmann RF. 2001. Sleep EEG, depression and gender. Sleep Med Rev 5:237-46.
10. Armitage R, Hoffmann RF, Rush AJ. 1999. Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms. Psychol Med 29:1435-48.
11. Armitage R, Hudson A, Trivedi M, Rush AJ. 1995. Sex differences in the distribution of EEG frequencies during sleep: unipolar depressed outpatients. J Affect Disord 34:12 1-9.
12. Armitage R, Roffwarg HP, Rush AJ. 1993. Digital period analysis of EEG in depression: periodicity, coherence, and interhemispheric relationships during sleep. Prog Neuropsychopharmacol Biol Psychiatry 17:363-72.
13. Armitage R, Roffwarg HP, Rush AJ, Calhoun JS, Purdy DG, Giles DE. 1992. Digital period analysis of sleep EEG in depression. Biol Psychiatry 31:52-68.
14. Armitage R, Smith C, Thompson S, Hoffmann R. 2001. Sex differences in slow-wave activity in response to sleep deprivation. Sleep Res Online 4:33-41.
15. Armitage R, Yonkers K, Cole D, Rush AJ. 1997. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 17:161-8.
16. Berger M, Riemann D. 1993. REM sleep in depression - an overview. J Sleep Res 2:211-23.
17. Berger M, Riemann D, Höchli D, Spiegel R. 1989. The cholinergic rapid eye movement sleep induction test with RS-86: state or trait marker for depression? Arch Gen Psychiatry 46:421-8.
18. Best NR, Rees MP, Barlow DH, Cowen PJ. 1992. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17:87-93.
19. Bitar MS, Ota M, Linnoila M, Shapiro GH. 1991. Modification of gonadectomy-induced increases in brain monamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology 16:547-57.
20. Bjorkqvist K. 2001. Social defeat as a stressor in humans. Physiol Behav 73:435-42.
21. Bohus B, Koolhaas JM, DeRuiter AJ, Heijnen CJ. 1991. Stress and differential alterations in immune system functions: conclusions from social stress studies in animals. Neth J Med 39:306-15.
22. Borbély A. 1982a. A two-process model of sleep regulation. Hum Neurobiol 1:195-204.
23. Borbély AA. 1982b. Sleep regulation: circadian rhythm and homeostasis. In: Ganten D, Pfaff D, editors. Sleep. Clinical and experimental aspects. Berlin: Springer. p 83-103.
24. Borbély AA, Tobler I, Loepfe M, Kupfer DJ, Ulrich RF, Grochocinski V, and others. 1984. All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Res 12:27-33.
25. Borbély AA, Wirz-Justice A. 1982. Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1:205-10.
26. Bowlby J. 1977a. The making and breaking of affectional bonds: I. Aetiology and psychopathology in the light of attachment theory. An expanded version of the Fiftieth Maudsley Lecture, delivered before the Royal College of Psychiatrists, 19 November 1976. Br J Psychiatry 130:201-10.
27. Bowlby J. 1977b. The making and breaking of affectional bonds: II. Some principles of psychotherapy. The Fiftieth Maudsley Lecture. Br J Psychiatry 130:421-31.
28. Brannan SK, Miller A, Jones DJ, Kramer GL, Petty F. 1995. Beta-adrenergic receptor changes in learned helplessness may depend on stress and test parameters. Pharmacol Biochem Behav 51:553-6.
29. Brown GW, Bifulco A, Harris T, Bridge L. 1986. Life stress, chronic subclinical symptoms and vulnerability to clinical depression. J Affect Disord 11:1-19.
30. Bunney WE, Davis J. 1965. Norepinephrine in depressive reactions: a review. Arch Gen Psychiatry 13:483-94.
31. Chamove AS, Rosenblum LA, Harlow HF. 1973. Monkeys (Macaca mulatta) raised only with peers. A pilot study. Anim Behav 21:316-25.
32. Charles HC, Lazeyras F, Krishnan RR, Boyko OB, Payne M, Moore D. 1994. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18:1121-7.
33. Chamey DS, Menkes DB, Heninger GR. 1981. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 38:1160-73.
34. Cheeta S, Ruigt G, van Proosdij J, Willner P. 1997. Changes in sleep architecture following chronic mild stress. Biol Psychiatry 41:419-27.
35. Comer MA, Mirmiran M, Bour H. 1980. On the role of active (REM) sleep in ontogenesis of the central nervous system. In: Koella WP, editor. Sleep '80. Basel: Karger. p 236-45.
36. Cullberg J. 1972. Mood changes and menstrual symptoms with different gestagen/estrogen combinations: a double-blind comparison with a placebo. Acta Psychiatr Scand 236:1-86.
37. Czeisler CA, Kronauer RE, Mooney JJ, Anderson JL, Allan JS. 1987. Biologic rhythm disorders, depression, and phototherapy. A new hypothesis. Psychiatr Clin North Am 10:687-709.
38. Depression Guideline Panel. 1993. Clinical practice guideline. Number 5. Depression in primary care: Volume 2: treatment of major depression, AHCPR Publication No. 93-0551. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.
39. Dilsaver SC, Coffman JA. 1989. Cholinergic hypothesis of depression: a reappraisal. J Clin Psychopharmacol 9:173-9.
40. Dube S. 1993. Cholinergic supersensitivity in affective disorders. In: Mann JJ, Kupfer DJ, editors. Biology of depressive disorders, Part A: a systems perspective. New York: Plenum. p 51-78.
41. Duman RS. 1999. The neurochemistry of mood disorders: preclinical studies. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiology of mental illness. New York: Oxford University Press. p 333-47.
42. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular hypothesis of depression. Arch Gen Psychiatry 54:597-606.
43. Dunleavy DL, Brezinova V, Oswald I, MacLean AW, Tinker M. 1972. Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry 120:663-72.
44. Edwards E, King JA, Fray JC. 1999. Increased basal activity of the HPA axis and renin-angiotensin system in congenital learned helpless rats exposed to stress early in development. Int J Dev Neurosci 17:805-12.
45. Edwards E, Kornrich W, van Houtten P, Henn FA. 1992. In vitro neurotransmitter release in an animal model of depression. Neurochem Int 21:29-35.
46. Ehlers C, Kaneko W, Owens MJ, Nemeroff CB. 1993. Effects of gender and social isolation on electroencephalogram and neuroendocrine parameters in rats. Biol Psychiatry 33:358-66.
47. Ende G, Braus DF, Kuhnen J, Henn FA. 1997. Proton MRSI in depressed patients undergoing electroconvulsive therapy: is Ch increased by ECT? Proc Int Soc Magn Reson Med 2:1167.
48. Fone KC, Shalders K, Fox ZD, Arthur R, Marsden CA. 1996. Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacology 123:346-52.
49. Freud S. 1966. The standard edition of the complete psychological works of Sigmund Freud. London: Hogarth.
50. Garvey MJ, Tollefson GD. 1984. Postpartum depression. J Reprod Med 29:113-6.
51. Gillin JC. 1983. The sleep therapies of depression. Prog Neuropsychopharmacol Biol Psychiatry 7:351-64.
52. Gillin JC, Sutton L, Ruiz C, Kelsoe J, Dupont RM, Darko D, and others. 1991. The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry 48:264-70.
53. Gillin JC, Wyatt RF, Fram D, Snyder F. 1978. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267-72.
54. Gur RC, Mozley LH, Mozley PD, Resnick SM, Karp JS, Alavi A, and others. 1995. Sex differences in regional cerebral glucose metabolism during a resting state. Science 267:528-31.
55. Gur RE, Gur RC. 1990. Gender differences in regional blood flow. Schizophr Bull 16:247-54.
56. Heim C, Owens MJ, Plotsky PM, Nemeroff CB. 1997. The role of early adverse life events in the etiology of depression and posttraumatic stress disorder. Focus on corticotropin-releasing factor. Ann N Y Acad Sci 821:194-207.
57. Heninger GR, Delgado PL, Chamey DS. 1996. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29:2-11.
58. Hobson JA, McCarley RW, Wyzinski PW. 1975. Sleep cycle oscillation: reciprocal discharge by two brain stem neuronal groups. Science 189:55.
59. Hochli D, Riemann D, Zulley J, Berger M. 1986. Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry 21:1217-20.
60. Hoffmann R, Hendrickse W, Rush AJ, Armitage R. 2000. Slow-wave activity during NREM sleep in men with schizophrenia and major depressive disorders. Psychiatry Res 95:215-25.
61. Hogan D, Roffwarg HP, Shaffery JP. 2001. The effects of 1 week of REM sleep deprivation on parvalbumin and calbindin immunoreactive neurons in central visual pathways of kittens. J Sleep Res 10:285-96.
62. Jaffe EH. 1998. Ca2+ dependency of serotonin and dopamine release from CNS slices of chronically isolated rats. Psychopharmacologia 139:255-60.
63. Janowsky DS, El Yousef MK, Davis JM. 1972. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632-5.
64. Janowsky DS, Fann WE, Davis JM. 1971. Monoamines and ovarian hormone-linked sexual and emotional changes. Arch Sex Behav 1:205-18.
65. Janowsky DS, Halbreich U, Rausch J. 1996. Association among ovarian hormones, other hormones, emotional disorders, and neurotransmitters. In: Jensvold MF, Halbreich U, Hamilton JA, editors. Psychopharmacology and women. Sex, gender, and hormones. Washington (DC): American Psychiatric Press. p 85-106.
66. Janowsky DS, Risch SC, Gillin JC. 1983. Adrenergic-cholinergic balance and the treatment of affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 7:297-307.
67. Janowsky DS, Risch C, Parker D, Huey L, Judd L. 1980. Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings]. Psychopharmacol Bull 16:29-31.
68. Keeney AJ, Hogg S. 1999. Behavioural consequences of repeated social defeat in the mouse: preliminary evaluation of a potential animal model of depression. Behav Pharmacol 10:753-64.
69. Kessler RC. 2000. Gender differences in major depression: epidemiological findings. In: Frank E, editor. Gender and its effects on psychopathology. Washington (DC): American Psychiatric Press. p 61-84.
70. Knowles JB, MacLean AW. 1990. Age-related changes in sleep in depressed and healthy subjects. A meta-analysis. Neuropsychopharmacology 3:251-9.
71. Koob GF, LeMoal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
72. Koolhaas JM, De Boer SF, De Rutter AJ, Meerlo P, Sgoifo A. 1997. Social stress in rats and mice. Acta Physiol Scand Suppl 640:69-72.
73. Kram ML, Kramer GL, Steciuk M, Ronan PJ, Petty F. 2000. Effects of learned helplessness on brain GABA receptors. Neurosci Res Suppl 38:193-8.
74. Kupfer DJ, Foster FG, Reich L, Thompson KS, Weiss R. 1976. EEG sleep changes in REM sleep and clinical depression. Am J Psychiatry 133:622-6.
75. Kupfer DJ, Frank E, Ehlers CL. 1989. EEG sleep in young depressives: first and second night effects. Biol Psychiatry 25:87-97.
76. Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ. 1990. Delta sleep ratio: a biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 47:1100-5.
77. Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski VJ, Wilson MJ, and others. 1991. Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry 29:23-40.
78. Kupfer DJ, Reynolds CF III, Ulrich RF, Grochocinski VJ. 1986. Comparison of automated REM and slow-wave sleep analysis in young and middle-aged depressed subjects. Biol Psychiatry 21:189-200.
79. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski V, Doman J, and others. 1984a. Application of an automated REM and slow wave sleep analysis: I. Normal and depressed subjects. Psychiatry Res 13:325-34.
80. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski V, Doman J, and others. 1984b. Application of an automated REM and slow wave sleep analysis: II. Testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatry Res 13:335-43.
81. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM. 2000. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res 122:81-103.
82. Ladd CO, Owens MJ, Nemeroff CB. 1996. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137:1212-8.
83. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, and others. 1997. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277:1659-62.
84. Manber R, Armitage R. 1999. Sex steroids and sleep: a review. Sleep 22:540-55 [Errata 523:145-9].
85. Mann JJ, Arango V. 1999. Abnormalities of brain structure and function in mood disorders. In: Chamey DS, Nestler EJ, Bunney BS, editors. Neurobiology of mental illness. New York: Oxford University Press. p 385-93.
86. Marrow LP, Overton PG, Brain PF. 1999. A re-evaluation of social defeat as an animal model of depression. J Psychopharmacol 13:115-21.
87. Marsh DM, Dougherty DM, Moeller FG, Swann AC, Spiga R. 2002. Laboratory-measured aggressive behavior of women: acute tryptophan depletion and augmentation. Neuropsychopharmacology 26:660-71.
88. Martin LJ, Spicer DM, Lewis MH, Gluck JP, Cork LC. 1991. Social deprivation of infant rhesus monkeys alters the chemoarchitecture of the brain: I. Subcortical regions. J Neurosci 11:3344-58.
89. Massaquoi SC, McCarley RW. 1992. The limit cycle reciprocal interaction model of REM cycle control: new neurobiological structure. J Sleep Res 1:138-43.
90. 1A) receptor activation. Life Sci 48:1627-32.
91. Matthews K, Wilkinson LS, Robbins TW. 1996. Repeated maternal separation of preweanling rats attenuates behavioral responses to primary and conditioned incentives in adulthood. Physiol Behav 59:99-107.
92. McCarley RW. 1982. REM sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 139:565-70.
93. McCarley RW, Hobson JA. 1975. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 189:58.
94. McCarley RW, Massaquoi SC. 1992. Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control, J Sleep Res 1:132-7.
95. Meerlo P, De Boer SF, Koolhaas JM, Daan S, Van den Hoofdakker RH. 1996. Changes in daily rhythms of body temperature and activity after a single social defeat in rats. Physiol Behav 59:735-9.
96. Meerlo P, Overkamp GJ, Benning MA, Koolhaas JM, Van den Hoofdakker RH. 1996. Long-term changes in open field behaviour following a single social defeat in rats can be reversed by sleep deprivation. Physiol Behav 60:115-9.
97. Meerlo P, Overkamp GJ, Daan S, Van den Hoofdakker RH, Koolhaas JM. 1996. Changes in behaviour and body weight following a single or double social defeat in rats. Stress 1:21-32.
98. Meerlo P, Overkamp GJ, Koolhaas JM. 1997. Behavioural and physiological consequences of a single social defeat in Roman high- and low-avoidance rats. Psychoneuroendocrinology 22:155-68.
99. Meerlo P, Pragt BJ, Daan S. 1997. Social stress induces high intensity sleep in rats. Neurosci Lett 225:41-4.
100. Meerlo P, Van den Hoofdakker RH, Koolhaas JM, Daan S. 1997. Stress-induced changes in circadian rhythms of body temperature and activity in rats are not caused by pacemaker changes. J Biol Rhythms 12:80-92.
101. Mendlewicz J, Dunbar GC, Hoffman G. 1985. Changes in sleep EEG architecture during the treatment of depressed patients with mianserin. Acta Psychiatr Scand 72:26-9.
102. Miller WR, Seligman ME. 1975. Depression and learned helplessness in man. J Abnorm Psychol 84:228-38.
103. Minot R, Luthringer R, Macher JP. 1993. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol 7:181-9.
104. Mirmiran M. 1986. The importance of fetal/neonatal REM sleep. Eur J Obstet Gynecol Reprod Biol 21:283-91.
105. Mirmiran M, Scholtens J, van de Poll NE, Uylings HBM, van der Gugten J, Boer GJ. 1983. Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behavior in the rat. Dev Brain Res 7:277-86.
106. Mirmiran M, van de Poll N, Cormer MA, van Oyen HG, Bour HL. 1981. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon sleep and behavior in the rat. Brain Res 204:129-46.
107. Monk TH, Buysse DJ, Frank E, Kupfer DJ, Dettling J, Ritenour AM. 1994. Nocturnal and circadian body temperatures of depressed outpatients during symptomatic and recovered states. Psychiatry Res 51:297-311.
108. Monleon S, D'Aquila P, Parra A, Simon VM, Brain PF, Willner P. 1995. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117:453-7.
109. Monti JM. 1989. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry 155:61-5.
110. Naruo T, Hara C, Nozoe S, Tanaka H, Ogawa N. 1993. Evaluation of depression in rats exposed to chronic (unpredictable) electric shock. Pharmacol Biochem Behav 46:667-71.
111. Nemeroff CB. 1998. The neurobiology of depression. Sci Am 278:42-9.
112. Nestler EJ. 1998. Antidepressant treatments in the 21st century. Biol Psychiatry 44:526-33.
113. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
114. Nofzinger EA, Reynolds CF III, Thase ME, Frank E, Jennings JR, Fasiczka AL, and others. 1995. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 152:274-6.
115. Overstreet DH. 1986. Selective breeding for increased cholinergic function: development of a new animal model of depression. Biol Psychiatry 21:49-58.
116. Overstreet DH. 1993. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17:51-68.
117. Overstreet DH, Janowsky DS, Pucilowski O, Rezvani AH. 1994. Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breeds of Flinders Line rats. Psychiatr Genet 4:101-7.
118. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS. 1995. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 121:27-37.
119. Overstreet DH, Russell RW. 1982. Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 78:150-5.
120. Papolos DF, Yu YM, Rosenbaum E, Lachman HM. 1996. Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides. Psychiatry Res 63:197-203.
121. Papp M, Klimek V, Willner P. 1994a. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology (Berl) 114:309-14.
122. Papp M, Klimek V, Willner P. 1994b. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) 115:441-6.
123. Parry BL. 2000. Hormonal basis of mood disorders in women. In: Frank E, editor. Gender and its effects on psychopathology. Washington (DC): American Psychiatric Press. p 3-21.
124. Perlis M, Smith MT, Orff H, Andreas P, Gillin JC, Giles D. 2002. The effects of an orally administered cholinergic agonist on REM sleep in depression. Biol Psychiatry 51:457-62.
125. Petty F, Kramer G, Wilson L, Jordan S. 1994. In vivo serotonin release and learned helplessness. Psychiatry Res 52:285-93.
126. Pfaff DW, Severino SK. 1996. Molecular approaches to sex differences in brain functions, including motivation and libido. In: Jensvold MF, Halbreich U, Hamilton JA, editors. Psychopharmacology and women. Sex, gender, and hormones. Washington (DC): American Psychiatric Press. p 107-20.
127. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr. 2001. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens. J Neurosci 21:7397-403.
128. Porsolt RD, Anton G, Blavet N, Jalfre M. 1978. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J. Pharmacol 47:379-91.
129. Pucilowski O, Overstreet DH. 1993. Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res Bull 32:471-5.
130. Pucilowski O, Overstreet DH, Rezvani AH, Janowsky DS. 1993. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54:1215-20.
131. Rampin C, Cespuglio R, Chastrette N, Jouvet M. 1991. Immobilisation stress induces a paradoxical sleep rebound in rat. Neurosci Lett 126:113-8.
132. Rausch JL, Parry BL. 1993. Treatment of premenstrual mood symptoms. Psychiatr Clin North Am 16:829-39.
133. Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, and others. 1997. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 41:837-43.
134. Renshaw PF, Lafer B, Christensen JD, Stoll AL, Rothschild AJ, Fava M, and others. 1994. Proton MRS of the basan ganglia in major depression. Biol Psychiatry 35:685.
135. Reynolds CF III, Kupfer DJ. 1987. Sleep research in affective illness: state of the art circa 1987. Sleep 10:199-215.
136. Rhodes ME, Rubin RT. 1999. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in manimals: a selective review. Brain Res Rev 30:135-52.
137. Riemann D, Berger M. 1992. Sleep, age, depression and the cholinergic REM induction test with RS 86. Prog Neuropsychopharmacol Biol Psychiatry 16:311-6.
138. Riemann D, Hohagen F, Bahro M, Berger M. 1994. Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86. Eur Arch Psychiatr Clin Neurosci 243:279-90.
139. Riemann D, Hohagen F, Krieger S, Gann H, Mfiller WE, Olbrich R, and others. 1994. Cholinergic REM induction test: muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia. J Psychiatr Res 28:195-210.
140. Riemann D, Hohagen F, Fritsch-Montero R, Krieger S, Gann H, Dressing H, and others. 1992. Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients. Acta Psychiatr Belg 92:151-71.
141. Riemann D, Hohagen F, Bahro M, Lis S, Stadmüller G, Gann H, and others. 1994. Cholinergic neurotransmission, REM sleep and depression. J Psychosom Res 38:15-25.
142. Roffwarg HP, Muzio JN, Dement WC. 1966. Ontogenetic development of the human sleep-dream cycle. Science 152:604-19.
143. Rosellini RA, DeCola JP, Plonsky M, Warren DA, Stilman AJ. 1984. Uncontrollable shock proactively increases sensitivity to response-reinforcer independence in rats. J Exp Psychol Anim Behav Process 10:346-59.
144. Rosellini RA, DeCola JP, Shapiro NR. 1982. Cross-motivational effects of inescapable shock are associative in nature. J Exp Psychol Anim Behav Process 8:376-88.
145. Ruppenthal GC, Arling GL, Harlow HF, Sackett GP, Suomi SJ. 1976. A 10-year perspective of motherless-mother monkey behavior. J Abnorm Psychol 85:341-9.
146. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, and others. 1998. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 44:3-14.
147. Russell RW, Overstreet DH, Messenger M, Helps SC. 1982. Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables. Pharmacol Biochem Behav 17:885-91.
148. Sampson D, Willner P, Muscat R. 1991. Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 104:491-5.
149. Schildkraut J, Kopin I, Schanberg S, Heninger D, Charney D. 1968. Norepinephrine metabolism and psychoactive drugs in the endogenous depression. Nachdruck aus Pharmacopsychiat 1:69-92.
150. Schildkraut JJ. 1965. The catecholamine hypothesis of affecfive disorders: a review of supporting evidence. Am J Psychiatry 122:509-22.
151. A receptors in specific brain regions by ovarian hormones. Neuroendocrinology 50:315-20.
152. Seligman ME, Weiss J, Weinraub M, Schulman A. 1980. Coping behavior: learned helplessness, physiological change and learned inactivity. Behav Res Ther 18:459-512.
153. Sharpley AL, Cowen PJ. 1995. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 37:85-98.
154. Shaw J, Kennedy SH, Joffe RT. 1995. Gender differences in mood disorders: A clinical focus. In: Seeman MV, editor. Gender and psychopathology. Washington (DC): American Psychiatric Press. p 89-111.
155. Shaw PJ, Tononi G, Greenspan RJ, Robinson DF. 2002. Stress response genes protect against lethal effects of sleep deprivation in Drosophila. Nature 471:287-91.
156. Shiromani PJ, Overstreet D, Levy D, Goodrich CA, Campbell SS, Gillin JC. 1988. Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology 1:127-33.
157. Siever LJ, Davis KL. 1985. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 142:1017-31.
158. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, Mendlewicz J. 1995. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 18:470-7.
159. Steingard RJ, Yurgelun-Todd DA, Hennen J, Moore JC, Moore CM, Vakili K, and others. 2000. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 48:1053-61.
160. 2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats. Life Sci 52:669-76.
161. Thase ME. 1998. Depression, sleep, and antidepressants. J Clin Psychiatry 59:55-65.
162. Thase ME, Frank E, Kornstein SG, Yonkers KA. 2000. Gender differences in response to treatments of depression. In: Frank E, editor. Gender and its effects on psychopathology. Washington (DC): American Psychiatric Press. p 103-29.
163. Tillet Y, Batailler M, Thibault J. 1993. Neuronal projections to the medial preoptic area of the sheep, with special reference to monoaminergic afferents: immunohistochemical and retrograde tract tracing studies. J Comp Neurol 330:195-220.
164. Van Bemmel AL, Beersma DGM, Van den Hoofdakker RH. 1993. Changes in EEG power density of NREM sleep in depressed patients during treatment with citalopram. J Sleep Res 2:156-62.
165. Van Bemmel AL, Van den Hoofdakker RH, Beersma DGM, Bouhuys AL. 1993. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 113:225-30.
166. Vogel G, Neill D, Hagler M, Kors D. 1990. A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14:85-91.
167. Vogel G, Neill D, Kors D, Hagler M. 1990. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev 14:77-83.
168. Vogel GW, Buffenstein A, Minter K, Hennessey A. 1990. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14:49-63.
169. Vogel GW, Traub AC, Ben Horin P, Meyers GM. 1968. REM deprivation: II. The effects on depressed patients. Arch Gen Psychiatry 18:301-11.
170. Vogel GW, Vogel F, McAbee RS, Thurmond AJ. 1980. Improvement of depression by REM sleep deprivation. New findings and a theory. Arch Gen Psychiatry 37:247-53.
171. Wagner HR, Hall TL, Cote IL. 1977. The applicability of inescapable shock as a source of animal depression. J Gen Psychol 96:313-8.
172. Weiss JM, Simson PE. 1988. Neurochemical and electrophysiological events underlying stress-induced depression in an animal model. Adv Exp MedBiol 245:425-40.
173. Willner P. 1984. The validity of animal models of depression. Psychopharmacology (Berl) 83:1-16.
174. Willner P. 1985. Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology (Berl) 85:387-404.
175. Willner P. 1995. Animal models of depression: validity and applications. Adv Biochem Psychopharmacol 49:19-41.
176. Willner P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134:319-29.
177. Willner P, Klimek V, Golembiowska K, Muscat R. 1991. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 19:79-84.
178. Willner P, Muscat R, Papp M. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-34.
179. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. 1987. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358-64.
180. Wirz-Justice A. 1995. Biological rhythms in mood disorders. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven, p 999-1017.
181. Wise RA. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
182. Wu J, Kramer GL, Kram M, Steciuk M, Crawford IL, Petty F. 1999. Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain. J Psychiatr Res 33:17-22.
183. Wu JC, Bunney WE. 1990. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147:14-21.
184. Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I, and others. 2000. Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol 62:353-78.
185. Yavari P, Vogel GW, Neill DB. 1993. Decreased raphe unit activity in a rat model of endogenous depression. Brain Res 611:31-6.